149 related articles for article (PubMed ID: 15622583)
1. Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer.
Papaconstantinou HT; Sklow B; Hanaway MJ; Gross TG; Beebe TM; Trofe J; Alloway RR; Woodle ES; Buell JF
Dis Colon Rectum; 2004 Nov; 47(11):1898-903. PubMed ID: 15622583
[TBL] [Abstract][Full Text] [Related]
2. De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population.
Buell JF; Papaconstantinou HT; Skalow B; Hanaway MJ; Alloway RR; Woodle ES
Transplant Proc; 2005 Mar; 37(2):960-1. PubMed ID: 15848590
[TBL] [Abstract][Full Text] [Related]
3. A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening.
Johnson EE; Leverson GE; Pirsch JD; Heise CP
J Gastrointest Surg; 2007 Mar; 11(3):272-9. PubMed ID: 17458597
[TBL] [Abstract][Full Text] [Related]
4. De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population.
Miao Y; Everly JJ; Gross TG; Tevar AD; First MR; Alloway RR; Woodle ES
Transplantation; 2009 May; 87(9):1347-59. PubMed ID: 19424035
[TBL] [Abstract][Full Text] [Related]
5. Lung Cancer Prognosis in Elderly Solid Organ Transplant Recipients.
Sigel K; Veluswamy R; Krauskopf K; Mehrotra A; Mhango G; Sigel C; Wisnivesky J
Transplantation; 2015 Oct; 99(10):2181-9. PubMed ID: 25839704
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients.
Bhat M; Mara K; Dierkhising R; Watt KDS
Mayo Clin Proc; 2018 Sep; 93(9):1236-1246. PubMed ID: 30064826
[TBL] [Abstract][Full Text] [Related]
7. Bladder cancer in renal allograft recipients: risk factors and outcomes.
Medani S; O'Kelly P; O'Brien KM; Mohan P; Magee C; Conlon P
Transplant Proc; 2014 Dec; 46(10):3466-73. PubMed ID: 25498074
[TBL] [Abstract][Full Text] [Related]
8. De novo malignancies after intestinal and multivisceral transplantation.
Abu-Elmagd KM; Zak M; Stamos JM; Bond GJ; Jain A; Youk AO; Ezzelarab M; Costa G; Wu T; Nalesnik MA; Mazariegos GV; Sindhi RK; Marcos A; Demetris AJ; Fung JJ; Reyes JD
Transplantation; 2004 Jun; 77(11):1719-25. PubMed ID: 15201672
[TBL] [Abstract][Full Text] [Related]
9. Incidence and treatment of cancer in transplant recipients.
Flattery MP
J Transpl Coord; 1998 Jun; 8(2):105-10; quiz 111-2. PubMed ID: 9727104
[TBL] [Abstract][Full Text] [Related]
10. Incidental diagnosis of gastric cancer in transplant recipients improves patient survival.
Buell JF; Husted T; Hanaway MJ; Peddi VR; Trofe J; Gross TG; Beebe TM; First MR; Woodle ES
Surgery; 2002 Oct; 132(4):754-8; discussion 758-60. PubMed ID: 12407362
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.
Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S
PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer after orthotopic liver transplantation.
Silva MA; Jambulingam PS; Mirza DF
Crit Rev Oncol Hematol; 2005 Oct; 56(1):147-53. PubMed ID: 16140543
[TBL] [Abstract][Full Text] [Related]
13. Malignancies of the colorectum and anus in solid organ recipients.
Aigner F; Boeckle E; Albright J; Kilo J; Boesmueller C; Conrad F; Wiesmayr S; Antretter H; Margreiter R; Mark W; Bonatti H
Transpl Int; 2007 Jun; 20(6):497-504. PubMed ID: 17343685
[TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
15. Nature and outcomes of the increased incidence of colorectal malignancy after liver transplantation in Australasia.
Verran DJ; Mulhearn MH; Dilworth PJ; Balderson GA; Munn S; Chen JW; Fink MA; Crawford MD; McCaughan GW
Med J Aust; 2013 Nov; 199(9):610-2. PubMed ID: 24182227
[TBL] [Abstract][Full Text] [Related]
16. De Novo Head and Neck Cancer After Liver Transplant With Antibody-Based Immunosuppression Induction.
Graham RC; Mella JS; Mangus RS
Transplant Proc; 2018 Dec; 50(10):3661-3666. PubMed ID: 30577252
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of colorectal cancer: what can we learn from the New Zealand Cancer Registry?
Keating J; Pater P; Lolohea S; Wickremesekera K
N Z Med J; 2003 May; 116(1174):U437. PubMed ID: 12766783
[TBL] [Abstract][Full Text] [Related]
18. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
19. Temporal Trends of De Novo Malignancy Development After Heart Transplantation.
Youn JC; Stehlik J; Wilk AR; Cherikh W; Kim IC; Park GH; Lund LH; Eisen HJ; Kim DY; Lee SK; Choi SW; Han S; Ryu KH; Kang SM; Kobashigawa JA
J Am Coll Cardiol; 2018 Jan; 71(1):40-49. PubMed ID: 29301626
[TBL] [Abstract][Full Text] [Related]
20. High rates of de novo malignancy compromise post-heart transplantation survival.
Giuliano K; Canner JK; Etchill E; Suarez-Pierre A; Choi CW; Higgins RSD; Hsu S; Sharma K; Kilic A
J Card Surg; 2021 Apr; 36(4):1401-1410. PubMed ID: 33567114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
